×
Organigram Holdings Receivables 2019-2024 | OGI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Organigram Holdings receivables from 2019 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Organigram Holdings Receivables 2019-2024 | OGI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Organigram Holdings receivables from 2019 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$199.9B
Stryker (SYK)
$137.7B
Boston Scientific (BSX)
$121.6B
Medtronic (MDT)
$113B
EssilorLuxottica (ESLOY)
$104.4B
Haleon (HLN)
$48.1B
Lonza Group Ag (LZAGY)
$45.4B
ResMed (RMD)
$35B
Koninklijke Philips (PHG)
$29B
Terumo (TRUMY)
$27.9B
Zimmer Biomet Holdings (ZBH)
$21.6B
Baxter (BAX)
$20.1B
Insulet (PODD)
$16.6B
Smith & Nephew SNATS (SNN)
$13.4B
Bio-Rad Laboratories (BIO)
$9.5B
Demant (WILYY)
$9.2B
BellRing Brands (BRBR)
$7.7B
Lantheus Holdings (LNTH)
$7.5B
ICU Medical (ICUI)
$4.3B
TG Therapeutics (TGTX)
$3.9B
Haemonetics (HAE)
$3.9B
Perrigo (PRGO)
$3.8B
GN Store Nord (GNNDY)
$3.8B
Neogen (NEOG)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Envista Holdings (NVST)
$3.3B
QuidelOrtho (QDEL)
$3.1B
Agios Pharmaceuticals (AGIO)
$2.6B
Maravai LifeSciences Holdings (MRVI)
$2.3B
Green Thumb Industries (GTBIF)
$2.2B